Liu Jingpeng, Huang Peng, Zhang Xiaoqing, Chen Yong, Zheng Xin, Shen Rufei, Tang Xuefeng, Yang Hui, Li Song
Department of Neurosurgery, Xinqiao Hospital, Army Medical University, Chongqing, China.
Multidisciplinary Center for Pituitary Adenomas of Chongqing, Chongqing, China.
J Korean Neurosurg Soc. 2023 Jan;66(1):72-81. doi: 10.3340/jkns.2022.0071. Epub 2022 Dec 30.
Ischemia and hemorrhage of pituitary adenomas (PA) caused important clinical syndrome. However, the differences on clinical characteristics and surgical outcomes between these two kinds apoplexy were less reported.
A retrospective analysis was made of patients with pituitary apoplexy between January 2013 and June 2018. Baseline and clinical characteristics before surgery were reviewed. All patients underwent transsphenoidal surgery and were followed up at least 1 year.
Total 67 cases (5.8%) among 1147 pituitary tumor patients were enrolled, which consisted of 28 (2.4%) ischemic PA and 39 (3.4%) hemorrhagic PA. There were more male patients in the ischemic group compared with hemorrhagic group (78.6% vs 53.8%, p=0.043). However, the mean age, tumor size and functional tumor ratio were significant higher in the hemorrhagic group. Headache was more common in ischemic PA (82.1%) than that of hemorrhagic PA (51.3%, p=0.011). Magnetic resonance imaging findings found that mucosal thickening and enhancement of the sphenoid sinus was observed in 15 ischemic PA patients (n=27, 55.6%), but none in patients with hemorrhagic PA (n=38, p<0.0001). It was worth noting that the rate of pre-surgical hypopituitarism in ischemic PA patients were seemed higher than that in hemorrhagic PA patients, but not significant. The two groups got a total tumor resection rate at 94.1% and 92.9%, independently. No significant difference on the operative time, blood loss in operation and complications in perioperative period was observed in two groups. After operation, cranial nerve symptoms recovered to normal at 81.8% of ischemic PA patients and 82.6% of hemorrhagic PA patients. Importantly, the incidence of postoperative hypopituitarism partially decreased in both groups, among which the rate of hypothyroidism in ischemic PA patients significantly decreased from 46.4% to 18.5% (p=0.044).
Patients with ischemic PA presented different clinical characteristics to the hemorrhagic ones. Transsphenoidal surgery should be considered for the patients with neuro-ophthalmic deficits and might benefit for pituitary function recovery of the apoplectic adenoma patients, especially pituitary thyroid axis in ischemic PA patients.
垂体腺瘤(PA)的缺血和出血可引发重要的临床综合征。然而,这两种卒中类型在临床特征和手术结果上的差异鲜有报道。
对2013年1月至2018年6月间垂体卒中患者进行回顾性分析。回顾手术前的基线和临床特征。所有患者均接受经蝶窦手术,并至少随访1年。
1147例垂体肿瘤患者中,共有67例(5.8%)纳入研究,其中缺血性PA患者28例(约2.4%),出血性PA患者39例(约3.4%)。与出血组相比,缺血组男性患者更多(78.6%对53.8%,p = 0.043)。然而,出血组的平均年龄、肿瘤大小和功能性肿瘤比例显著更高。缺血性PA患者头痛比出血性PA患者更常见(82.1%对51.3%,p = 0.011)。磁共振成像结果显示,15例缺血性PA患者(n = 27,55.6%)观察到蝶窦黏膜增厚和强化,而出血性PA患者无一例出现(n = 38,p < 0.0001)。值得注意的是,缺血性PA患者术前垂体功能减退的发生率似乎高于出血性PA患者,但差异无统计学意义。两组的肿瘤全切除率分别为94.1%和92.9%。两组在手术时间、术中出血量和围手术期并发症方面无显著差异。术后,缺血性PA患者81.8%的颅神经症状恢复正常,出血性PA患者为82.6%。重要的是,两组术后垂体功能减退的发生率均有所下降,其中缺血性PA患者甲状腺功能减退率从46.4%显著降至18.5%(p = 0.044)。
缺血性PA患者与出血性PA患者具有不同的临床特征。对于有神经眼科缺陷的患者应考虑经蝶窦手术,这可能有益于卒中性腺瘤患者垂体功能的恢复,尤其是缺血性PA患者的垂体 - 甲状腺轴。